Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001968974 | SCV002249055 | benign | not provided | 2022-12-06 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001968974 | SCV003825765 | uncertain significance | not provided | 2021-07-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004044649 | SCV004957140 | uncertain significance | Inborn genetic diseases | 2021-10-08 | criteria provided, single submitter | clinical testing | The c.6385C>T (p.R2129W) alteration is located in exon 32 (coding exon 31) of the SPTBN2 gene. This alteration results from a C to T substitution at nucleotide position 6385, causing the arginine (R) at amino acid position 2129 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |